DNA Vaccines Expressing Pneumococcal Surface Protein A (PspA) Elicit Protection Levels Comparable to Recombinant Protein

This article, published in the Journal of Medical Microbiology, provide results that show that DNA vaccines expressing PspA are able to elicit protection levels comparable to recombinant protein, even though total anti-PspA IgG response is considerably lower.

Author(s): Ferreira DM, Miyaji EN, Oliveira MLS, et al.

Published: 2006

  • Visit web page (English)

    (Located at jmm.sgmjournals.org)

    Citation: Ferreira DM, Miyaji EN, Oliveira MLS, et al. DNA Vaccines Expressing Pneumococcal Surface Protein A (PspA) Elicit Protection Levels Comparable to Recombinant Protein. Journal of Medical Microbiology. 2006;55(4):375-378.

Resource types: Peer-reviewed journal

Diseases: Pneumococcus

Topics: Disease/vaccine specific information

Regions: Global